International Women’s Day 2023

Tips on career advancement, from some of LifeArc’s incredible women

Honouring the contribution of a remarkable trustee – Aisling Burnand CBE

Melanie Lee pays tribute to Aisling Burnand and her immense contribution to the life sciences sector.

Rare Disease Day 2023 – Robbie’s story

Robbie has a rare genetic neurodegenerative disease known as AP-4 Hereditary Spastic Paraplegia (AP-4 HSP) subtype SPG47.

Four ways we support rare disease research

LifeArc provides a range of advice, funding and science to help scientists turn promising research into potential treatments.

LifeArc awards £3 million to advance promising early rare disease research from the lab to the patient

Pump-prime funding to help researchers get innovative approaches off the ground

Celebrating the International Day of Women and Girls in Science

LifeArc celebrates this year's UN Day for Women and Girls in STEM.

Alzheimer’s drug lecanemab approved by US regulator

LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the FDA.

2022 wrapped – our highlights from a pivotal year

We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.

MND Collaborative Partnership cautiously welcomes new Government funding

We cautiously welcome the Government's announcement on how their £50m commitment into MND research will be spent.